This episode of the Massey Dialogues discusses key aspects of this all-hands-on-deck response. For a more unique perspective, we look not just at what we know or what we are doing to respond, but how our response has, and will, come together. Through discussion with our distinguished guests, we will explore a range of topics, from learning how our public health and healthcare systems were constructed to confront pandemic diseases to hearing the collaborative efforts that are vital towards producing ventilators, personal protective equipment and other medical supplies at-scale. Through this conversation, viewers will better understand the scope of our country’s response, the behind-the-scenes actions being taken to help us move towards the best-case scenarios and how collaboration can help overcome immense challenges.
This Dialogue will be hosted by Paul Chen, a Junior Fellow pursuing his PhD in the Department of Chemical Engineering & Applied Chemistry. Paul will be joined in conversation with Senior Fellow Dr. Natasha Crowcroft from the Dalla Lana School of Public Health, and Flavio Volpe, President of the Automotive Parts Manufacturers Association.
The Dialogues are open to the public – we invite everyone to join and take part in what will be a very informative online discussion.
Click here Thursday at 5:00pm EST to join this livestream event. Participants are invited to submit questions to the speakers in real time via the youtube channel’s chat function as well as through Twitter with the hashtag #MasseyDialogues.
Paul Chen is a first-year resident Junior Fellow and fourth-year PhD student in the Department of Chemical Engineering & Applied Chemistry. His doctoral research investigates how nanocrystals grow at the atomic scale, uses that insight to design nanomaterials with enhanced or emergent properties and applies those nanomaterials to develop biomedical technologies. He is the current Head of Programming of Science Rendezvous — University of Toronto, an organization that hosts outreach events throughout the Greater Toronto Area, including an annual day-long festival that averages 30,000 attendees, to spur children’s interest in S.T.E.A.M. and to improve scientific literacy in the public. Prior to joining the University of Toronto, Paul conducted research at the University of Waterloo, Harvard Medical School and Brigham & Women’s Hospital. Paul received his BASc in Nanotechnology Engineering from the University of Waterloo in 2016.
Dr. Natasha Crowcroft is a public health medical practitioner with more than 25 years’ experience in public health at local, national and global levels, and two decades of senior management and leadership experience in infectious disease surveillance, prevention, control and outbreak response. She has published over 250 peer-reviewed scientific papers including in Lancet, BMJ, NEJM, with an h-factor of 47 (Google scholar). She is an Associate Editor for Eurosurveillance and on the International Advisory Board of Lancet Infectious Diseases. With a strong track record of research funding, she reviews for a variety of national and global funding bodies. Her research aims to maximize the health benefits of immunization.
Dr. Crowcroft’s expert role includes as current co-chair of the Canadian Association for Immunization Research, Evaluation and Education (CAIRE), and member of the Canadian Immunization Research Network. Globally, she is an expert for PAHO, SEARO and WHO and also serves on the Independent Review Committee of Gavi.
Dr. Crowcroft trained in medicine and public health at the Universities of Cambridge and London, UK, and in field epidemiology in the European Programme for Intervention Epidemiology Training (EPIET) in Belgium. From 1997-2007 Dr. Crowcroft was a medical consultant in the Immunisation Department at the national centre for England. In 2007 she was recruited to be one of the founding leadership group at Public Health Ontario, Canada, helping to rebuild the public health system post-SARS. She became Director of Surveillance and Epidemiology in 2008, Chief of Infectious Disease in 2012, Chief of Applied Immunization Research and Evaluation in 2015, and Chief Science Officer in 2019. In 2019, Dr. Crowcroft launched the Centre for Vaccine Preventable Diseases at the University of Toronto as its inaugural Director.
Flavio Volpe is a champion of Canada’s globally relevant automotive sector and is dedicated to the growth of Canada’s automotive innovation, the development of new markets and the leveraging of its international leadership. Representing the interests of suppliers at home and abroad, he proudly leads the Automotive Parts Manufacturers’ Association (APMA) – Canada’s national association representing OEM producers of parts, equipment, tools, supplies and services for the worldwide automotive industry.
Working closely with officials in all three countries during the NAFTA renegotiations, he led the industry’s effort to secure an unprecedented increase in regional value content for automotive suppliers in the new USMCA.
Flavio speaks regularly on behalf of industry interests, opportunities and challenges in Canada and abroad and is a sought-after voice by leading global publications including The Economist, New York Times, Wall Street Journal, BBC, CNBC, Globe and Mail and Washington Post. Flavio was recognized as Industry Leader of the Year by Automotive News Canada in 2017 and again in 2018.
Previous to APMA he served as Managing Director, Canada of WIRSOL AG, the EU’s largest privately-held solar photovoltaic energy developer, and as Chief of Staff to the Ontario Minister of Economic Development and Trade.
Flavio holds a Master’s in Business Administration from the Schulich School of Business at York University and a Bachelor’s degree in International Relations from the University of Toronto.